cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Biovie Inc
2 own
3 watching
Current Price
$5.41
$-0.28
(-4.92%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
174.43M
52-Week High
52-Week High
14.38
52-Week Low
52-Week Low
1.325
Average Volume
Average Volume
0.12M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization174.43M
icon52-Week High14.38
icon52-Week Low1.325
iconAverage Volume0.12M
iconDividend Yield--
iconP/E Ratio--
What does the Biovie Inc do?
BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer s disease and Phase I clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is based in Santa Monica, California.
Read More
How much money does Biovie Inc make?
News & Events about Biovie Inc.
Accesswire
10days ago
ORLANDO, FL / ACCESSWIRE / January 25, 2023 / RedChip Companies is pleased to announce its CEO, Dave Gentry, was recently welcomed as a member of the Forbes Business Council.The Forbes Business Council committee invited Gentry to join the elite group of business leaders in recognition of his...
Fool.com Headlines
30days ago
The biotech announced positive news from a pair of phase 2 clinical trials.Shares of biotech BioVie (NASDAQ: BIVI) rose 15.3% in December, according to data provided by S&P Global Market Intelligence. The stock closed November at $6.74 a share. It climbed to as high as $14.38 on Dec. 16, before ...
Accesswire
1month ago
ORLANDO, FL / ACCESSWIRE / December 29, 2022 / RedChip Companies will air a new interview BioVie Inc. (NASDAQ:BIVI) ('BioVie' or the 'Company'), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and...
Accesswire
1month ago
NEW YORK, NY / ACCESSWIRE / December 13, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issued a new C-Level interview with BioVie.Toni had the pleasure of recently conducting the Interview...
PR Newswire
1month ago
Thinking about buying stock in Carvana, BioVie, Airbnb, RLX Technology, or Melco Resorts & Entertainment? Thinking about buying stock in Carvana, BioVie, Airbnb, RLX Technology, or Melco Resorts & Entertainment? PR Newswire NEW YORK, Dec. 7, 2022 NEW YORK, Dec. 7, 2022 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Biovie Inc share price today?
plus_minus_icon
Can Indians buy Biovie Inc shares?
plus_minus_icon
How can I buy Biovie Inc shares from India?
plus_minus_icon
Can Fractional shares of Biovie Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Biovie Inc stocks?
plus_minus_icon
What is today’s traded volume of Biovie Inc?
plus_minus_icon
What is today’s market capitalisation of Biovie Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Biovie Inc?
plus_minus_icon
What percentage is Biovie Inc down from its 52-Week High?
plus_minus_icon
What percentage is Biovie Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.41
$-0.28
(-4.92%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00